• 페이스북 공유
  • 트위터 공유
  • 미투데이 공유
  • URL복사
  • 더보기
  • 관심의료진 등록

신상원

신상원

신상원 교수의 진료시간표 진료예약

진료과/센터 전문진료과목
종양혈액내과
오후
- -
종일
- - 두경부암 , 폐암 , 호스피스
암센터
오후
- -
종일
- - 두경부암 , 폐암 , 호스피스

신상원 교수의 상세정보

학력

more
  •  ~  1984 .02  :  Korea University College of Medicine
  •  ~  1994 .02  :  Korea University Graduate school, Ph.D

경력

more
  • 1997 .01  ~   :  Visiting Scientist in National Cancer Institute, USA
  • 1999 .01  ~   :  Research Associate in Dana-Farbar Cancer Institute, Boston USA
  • 2007 .01  ~   :  Visiting Scholar in UCLA. USA

학회활동

more
  • 2007 .01  ~   :  Korea Hospice Palliative Care Society, Board Member
  • 2009 .01  ~   :  Korea Cancer Society, Board Member
  • 2009 .01  ~   :  한국 호스피스 완화의료 학회 이사

논문

more
  • [국외논문] (A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations)
  • [국외논문] (Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy)
  • [국외논문] (Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea)
  • [국외논문] (Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy)
  • [국외논문] (Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer)
  • [국외논문] (Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?)

최종수정일 : 2018.01.12